A*Star
Singapore Institutions Launch Program to Diagnose, Treat EBV-Associated Nasopharyngeal Cancer
The program, funded by Singapore's National Research Foundation, aims to identify Epstein-Barr virus strains associated with NPC in Southeast Asian populations.
VarNet, developed at A*STAR, applies "weakly supervised" AI and DNA image representations to remove human variability in variant calling and mutation detection.
Single-Cell Analysis of Colorectal Cancer Uncovers Two Epithelial-Cell Based Subtypes
The researchers further proposed a new classification system for the disease that includes epithelial subtype, microsatellite status, and whether fibrosis is present.
A*STAR Wins $2M Chan Zuckerberg Initiative Grant to Advance Asian Immune Cell Atlas
The Asian Immune Diversity Atlas aims to sequence millions of peripheral blood mononuclear cells from over 2,000 healthy ancestrally diverse Asian people.
MiRxes Raises $77M in Series C Round to Speed Progress of Early Cancer Detection Tests
The Singapore-based company's tests look for blood-borne microRNA and other molecular signatures released by cancer and immune cells.